Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncology Letters|March 29, 2020
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapyYuko Nakazawa, Seshiru Nakazawa, Sasagu Kurozumi, et al.
Breast Cancer (Tokyo, Japan)|January 20, 2005
Two cases of breast cancer with cartilaginous and osseous metaplasiaJun Ninomiya, Tetsunari Oyama, Jun Horiguchi, et al.
Endocrine|May 29, 2007
Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cellsRin Nagaoka, Toshiharu Iwasaki, Nana Rokutanda, et al.
Surgery Today|March 28, 2007
Combined liver and inferior vena cava resection for adrenocortical carcinomaSusumu Ohwada, Masaru Izumi, Yoshifumi Tanahashi, et al.
International Journal of Nanomedicine|October 11, 2022
Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast CancerYoshimasa Kosaka, Toshiaki Saeki, Toshimi Takano, et al.
Breast Cancer (Tokyo, Japan)|February 27, 2009
Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsyNana Rokutanda, Jun Horiguchi, Yukio Koibuchi, et al.
Breast Cancer (Tokyo, Japan)|November 25, 2003
Long-term suppression of lymphangitic lung metastasis from breast cancer using biweekly docetaxel: a case reportJun Ninomiya, Jun Horiguchi, Yukio Koibuchi, et al.
Oncology Reports|October 8, 2005
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancerJun Horiguchi, Yukio Koibuchi, Kotaro Iijima, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2026
Peliosis Hepatis Induced by Tamoxifen Therapy in a Patient with Breast CancerEriko Narusawa, Shohei Kodama, Takashi Hoshino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 18, 2008
[A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer]Jun Horiguchi, Yukio Koibuchi, Nana Rokutanda, et al.
Pageof 4